Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development

Elżbieta Bronisz1, Iwona Kurkowska-Jastrzębska1

  • 12nd Department of Neurology, Institute of Psychiatry and Neurology, Jana III Sobieskiego 9, 02-957 Warsaw, Poland.

Mediators of Inflammation
|January 21, 2017
PubMed

Insights

Matrix metalloproteinase 9 (MMP-9) is a key biomarker implicated in epilepsy. Elevated MMP-9 levels in the epileptic focus contribute to seizure generation and formation, highlighting its role in neurological damage.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Biomarker Research

Background:

  • Matrix metalloproteinase 9 (MMP-9) is a proteolytic enzyme increasingly studied as a biomarker.
  • MMP-9 is implicated in neuronal damage across various conditions, including stroke, heart disease, tumors, multiple sclerosis, and epilepsy.
  • In epilepsy, MMP-9 is suggested to be involved in the formation of the epileptic focus and seizure stimulation.

Purpose of the Study:

  • To review and summarize existing research on the association between MMP-9 and epilepsy.
  • To discuss the mechanisms by which MMP-9 influences epilepsy.
  • To present findings from both animal models and clinical studies regarding MMP-9 in epilepsy.

Main Methods:

  • Literature review of previous studies on MMP-9 and epilepsy.
  • Analysis of data from animal models of epilepsy.
  • Examination of clinical study results concerning MMP-9 levels in epilepsy patients.

Main Results:

  • Increased MMP-9 activity is observed in the epileptic focus in both animal models and clinical studies.
  • MMP-9 contributes to epileptic focus formation through mechanisms like synaptic remodeling.
  • MMP-9's actions on the blood-brain barrier and glutamatergic transmission are linked to seizure induction and inflammation.

Conclusions:

  • MMP-9 plays a significant role in the pathophysiology of epilepsy.
  • MMP-9's involvement in synaptic remodeling, blood-brain barrier integrity, and neuronal transmission suggests its potential as a therapeutic target.
  • Further research comparing MMP-9 levels across studies is needed to establish its utility as a reliable biomarker for epilepsy activity.